Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

View today's Astellas Pharma Inc. stock price and latest 4503 news and analysis. Create real-time notifications to follow any changes in the live stock price.

View the latest Astellas Pharma Inc. ADR (ALPMY) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Review quarterly and annual revenue, net income, and cash flow for Astellas Pharma Inc (ALPMF:PINX) stock through the last fiscal year.

Astellas Pharma has bought bioelectronic medical devices firm iota Biosciences in a deal worth up to $429m, building on a previous research partnership.

Get the detailed quarterly/annual income statement for Astellas Pharma Inc. (ALPMY). Find out the revenue, expenses and profit or loss over the last fiscal year.

Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug ...

Good morning, we have news of a big M&A deal this morning. Let’s get into it. Merck said this moring that it will buy Verona ...

Astellas has shored up the competitive profile of Izervay for eye disorder geographic atrophy, getting FDA approval for extended treatment.

Pfizer also maintains collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US Inc., Myovant Sciences Ltd., Merck KGaA, Valneva SE, BioNTech SE and Arvinas, Inc.